Literature DB >> 17045483

A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr.

R G Selwyn1, R J Nickles, B R Thomadsen, L A DeWerd, J A Micka.   

Abstract

(90)Y is utilized as a therapeutic radioisotope in radiolabeled monoclonal antibodies and in microspheres for targeted radiation therapy of the liver. Currently, the widely used dose calibrator assay of (90)Y can have uncertainties exceeding +/-10%. A non-destructive assay using spectroscopy is possible by reducing the currently published uncertainty (+/-12%) in the internal pair production branching ratio for the 0(+)-0(+) transition of (90)Zr. A high-purity germanium detector was used to determine the branching ratio to be (31.86+/-0.47) x 10(-6).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17045483     DOI: 10.1016/j.apradiso.2006.08.009

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  38 in total

1.  PET/CT imaging of ⁹⁰Y radiation synovectomy.

Authors:  Thomas W Barber; Kenneth S K Yap; Victor Kalff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05       Impact factor: 9.236

2.  Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres.

Authors:  Renaud Lhommel; Larry van Elmbt; Pierre Goffette; Marc Van den Eynde; François Jamar; Stanislas Pauwels; Stephan Walrand
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-27       Impact factor: 9.236

3.  Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT.

Authors:  Renaud Lhommel; Pierre Goffette; Marc Van den Eynde; François Jamar; Stanislas Pauwels; Jose I Bilbao; Stephan Walrand
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-07-18       Impact factor: 9.236

Review 4.  Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?

Authors:  Stephan Walrand; Glenn D Flux; Mark W Konijnenberg; Roelf Valkema; Eric P Krenning; Renaud Lhommel; Stanislas Pauwels; Francois Jamar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-11       Impact factor: 9.236

Review 5.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

6.  Nuclear Theranostics in Taiwan.

Authors:  Ko-Han Lin; Yi-Wei Chen; Rheun-Chuan Lee; Ling-Wei Wang; Fong-In Chou; Chi-Wei Chang; Sang-Hue Yen; Wen-Sheng Huang
Journal:  Nucl Med Mol Imaging       Date:  2019-02-01

7.  Clinical feasibility of 90Y digital PET/CT for imaging microsphere biodistribution following radioembolization.

Authors:  Chadwick L Wright; Katherine Binzel; Jun Zhang; Evan J Wuthrick; Michael V Knopp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-12       Impact factor: 9.236

Review 8.  Update on novel trends in PET/CT technology and its clinical applications.

Authors:  Stephan Walrand; Michel Hesse; François Jamar
Journal:  Br J Radiol       Date:  2016-11-25       Impact factor: 3.039

9.  Cerenkov imaging - a new modality for molecular imaging.

Authors:  Daniel Lj Thorek; Robbie Robertson; Wassifa A Bacchus; Jaeseung Hahn; Julie Rothberg; Bradley J Beattie; Jan Grimm
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

10.  Practical reconstruction protocol for quantitative (90)Y bremsstrahlung SPECT/CT.

Authors:  W Siman; J K Mikell; S C Kappadath
Journal:  Med Phys       Date:  2016-09       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.